Special Event
COVID-19 Clinical Trials: The Critical Need to Include People with Kidney Diseases
October 25, 2020 | 10:30 AM - 12:30 PM
Location: Simulive
Session Description
Clinical trials often exclude people with kidney diseases. This means that 37 million Americans are rarely represented in research that changes treatment and care. The Kidney Health Initiative is championing the inclusion of people with kidney diseases in COVID-19 trials to address the substantial clinical need in the coming months and years. This event shares the latest information and strategies that may reduce risk and transmission as COVID-19 vaccines and therapies become available.
Note: Continuing education credits are not being offered for this activity.
